EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays

Tumor-associated autoantibodies (AAbs) have been described in patients with lung cancer, and the EarlyCDT®-Lung test that measures such AAbs is available as an aid for the early detection of lung cancer in high-risk populations. Improvements in specificity would improve its cost-effectiveness, as we...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Chapman, Caroline J., Healey, Graham F., Murray, Andrea, Boyle, Peter, Robertson, Chris, Peek, Laura J., Allen, Jared, Thorpe, Alison J., Hamilton-Fairley, Geoffrey, Parsy-Kowalska, Celine B., MacDonald, Isabel K., Jewell, William, Maddison, Paul, Robertson, John F. R.
Formato: Artigo
Idioma:Inglês
Publicado: Springer Netherlands 2012
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3460172/
https://ncbi.nlm.nih.gov/pubmed/22492236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13277-012-0379-2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares